Evotec SE (EVO) Common Equity (2009 - 2026)

Evotec SE has disclosed Common Equity across 10 years of filings, most recently posting $773.6 million for Q2 2026.

• In Q2 2026, Common Equity fell 19.19% year-over-year to $773.6 million; the TTM figure through Jun 2026 stood at $773.6 million (down 19.19% YoY), while the FY2025 annual figure was $919.3 million, down 10.83% from the prior year.
• Common Equity came in at $773.6 million for Q2 2026 at Evotec SE, down from $819.1 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.5 billion in Q1 2022 to a low of $773.6 million in Q2 2026.
• Average Common Equity over 5 years is $1.1 billion, with a median of $1.0 billion recorded in 2024.
• The largest YoY upside for Common Equity was 5.81% in 2022 against a maximum downside of 23.15% in 2022.
• Over 5 years, Common Equity stood at $1.2 billion in 2022, then declined by 0.52% to $1.2 billion in 2023, then fell by 15.53% to $1.0 billion in 2024, then dropped by 6.94% to $947.2 million in 2025, then fell by 18.32% to $773.6 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $773.6 million in Q2 2026, $819.1 million in Q1 2026, and $947.2 million in Q4 2025.